NéoVac (Neonatal Vaccination against Hepatitis B in Africa)
Chronic infection with hepatitis B virus (HBV) is an important cause of premature adult deaths in sub-Saharan Africa (SSA), due to liver cancer or cirrhosis. To reduce the disease burden, it is critical to […]
Community-based home visit intervention in sub-Saharan Africa to improve Hepatitis B vaccination coverage at birth and neonatal survival (Neovac)
The aim of this study is to develop and evaluate a community-based home visit intervention in sub-Saharan Africa to improve the coverage of a timely birth dose of HBV vaccine and neonatal care practices […]
Hepatitis B in Burkina Faso and Central African Republic
As a follow-up to ANRS funding for a feasibility study (ANRS 12232), I received in 2011 funding from ANRS for an in-depth anthropological study of hepatitis B and vaccination in Bobo Dioulasso and the […]
A multi-disciplinary study of human beings, great apes, and viral emergence in equatorial Africa (SHAPES)
This multi-disciplinary study examines the changing nature and contexts of human contact with great apes and monkeys in equatorial Africa and the health consequences of that contact. Biomedical researchers have scrutinized the nature of […]
TORCADIA : Epidemiology of severe childhood diarrhea: A case control study in the Central African Republic (CAR)
(Collaborators: Sébastien Breurec, Ionela Gouandjika,Thierry Frank, Caroline Martin (IP Bangui), Petulla bata, Jean Gody (Complexe pédiatrique Bangui), Tamara Giles-Vernick, Loic chartier, Muriel Vray (IP Paris)). Funding : The fondation Total. Diarrhea ranks as the […]
MACOMBA : Pragmatic clinical trial comparing a prophylactic treatment of cotrimoxazole (CTX) with sulfadoxine-pyriméthamine (SP) for malaria among pregnant women infected with HIV in Bangui
(Collaborators: Alexandre Manirakiza, Sandrine Moussa, Aude Boulay, Olga Sakanga, Sébastien Breurec, Mirdad Kazanji(IP Bangui), Lenaig Le-Fouler, Muriel Vray (IP Paris)). Funding : Fondation de France. Accounting for HIV serological status in patients is critically […]
2021The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study)., Vaccines (Basel) 2021 May; 9(5): .
2021Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings., Clin Microbiol Infect 2021 Apr; (): .
2021Identification of Pathogens Potentially Associated with Non-Malarial Fever in Children: A Pilot Study in Peri-Urban Dakar, Senegal., Am J Trop Med Hyg 2021 Feb; (): .
2021Evaluating the motivation of Red Cross Health volunteers in the COVID-19 pandemic: a mixed-methods study protocol., BMJ Open 2021 01; 11(1): e042579.
2021Evaluating the motivation of Red Cross Health volunteers in a pandemic: A mixed-methods protocol, BMJ Open.
2021Performance of case definitions and clinical predictors for influenza surveillance among patients followed in a rural cohort in Senegal., BMC Infect Dis 2021 Jan; 21(1): 31.
2020Klebsiella pneumoniae carriage in low-income countries: antimicrobial resistance, genomic diversity and risk factors., Gut Microbes 2020 09; 11(5): 1287-1299.
2020Mobile Laboratory Reveals the Circulation of Dengue Virus Serotype I of Asian Origin in Medina Gounass (Guediawaye), Senegal., Diagnostics (Basel) 2020 Jun; 10(6): .
2020Tuberculosis trends in a hot-spot region in Paris, France., Int J Tuberc Lung Dis 2020 04; 24(4): 428-435.
2020Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients., Clin Infect Dis 2020 Mar; 70(7): 1471-1477.
+Voir la liste complète de publications